Skip to search formSkip to main contentSkip to account menu

pioglitazone

Known as: Pioglitazonum, (+-)-5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione, Pioglitazona 
An orally-active thiazolidinedione with antidiabetic properties and potential antineoplastic activity. Pioglitazone activates peroxisome proliferator… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
To describe a protocol for active surveillance of acute myocardial infarction (AMI) in users of a recently approved oral… 
Highly Cited
2008
Highly Cited
2008
AIMS To examine possible effects of polymorphism in the SLCO1B1 gene, encoding the hepatic uptake transporter organic anion… 
Highly Cited
2007
Highly Cited
2007
Objective—Although emerging data from preclinical and clinical studies suggests a reduction of in-stent restenosis with… 
2006
2006
Objective   It has been reported that both normal pituitary and pituitary tumours express PPAR‐γ, a nuclear hormone receptor, the… 
Highly Cited
2004
Highly Cited
2004
The interaction between leukocytes and the vascular endothelial cells (EC) via cellular adhesion molecules plays an important… 
Highly Cited
1996
Highly Cited
1996
Pioglitazone (a thiazolidinedione derivative) increases insulin sensitivity and prevents hypertension in the Dahl-salt-sensitive… 
Highly Cited
1996
Highly Cited
1996
The effects of pioglitazone, a novel antidiabetic insulin-sensitizing agent, on insulin signaling in skeletal muscles from…